Sedative-Anxiolytic Effects on Simulated Driving Performance

NCT03297944 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Psychomotor Impairment

Interventions

DRUG: Alprazolam 2mg (2ALP/PLC)
DRUG: Alprazolam 1mg (1ALP/PLC)
DRUG: Alprazolam 0.5mg (0.5ALP/PLC)
DRUG: Zolpidem 10mg (ZOL/PLC)
DRUG: Placebo (PLC/PLC)
DRUG: Alprazolam 1mg (PLC/ALC)

Sponsor

Marion Coe

Collaborators

[object Object]